Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001213850 | SCV001385501 | pathogenic | not provided | 2023-09-18 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 2188 of the EYS protein (p.Ile2188Thr). This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Ile2188 amino acid residue in EYS. Other variant(s) that disrupt this residue have been observed in individuals with EYS-related conditions (PMID: 31213501), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on EYS protein function. ClinVar contains an entry for this variant (Variation ID: 943623). This missense change has been observed in individual(s) with autosomal recessive retinitis pigmentosa (PMID: 26161267, 29159838; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. |
Baylor Genetics | RCV003469359 | SCV004192864 | pathogenic | Retinitis pigmentosa 25 | 2024-02-27 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003887912 | SCV004707463 | pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research |